AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
LifeStance Expands Clinician Base, Raises EBITDA Guidance for 2025
ByAinvest
Friday, Aug 8, 2025 2:06 am ET1min read
LifeStance Health Group has raised its adjusted EBITDA guidance and targets double-digit margins for FY2025. The company expanded AI and clinician initiatives, growing its clinician base by over 170 clinicians. CEO David Patrick Bourdon highlighted strong Q2 results, stating the company met or exceeded each of its guided metrics.
LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, has reported robust financial results for the second quarter ended June 30, 2025, and raised its adjusted EBITDA guidance for the full year. The company announced that its adjusted EBITDA for the second quarter increased by 19% to $34.0 million, driven by double-digit organic revenue growth and improved operating leverage [1].CEO David Patrick Bourdon highlighted the company's strong performance, stating, "We grew our clinician base by over 170 clinicians while at the same time improving productivity. We delivered double-digit organic revenue growth along with 10% Adjusted EBITDA margins, and are raising our full year guidance midpoint for Adjusted EBITDA by $5 million" [1].
The company's revenue grew 11% to $345.3 million, with visit volumes increasing by 12% to 2.2 million. The net loss was $3.8 million, down from $23.3 million in the prior year. LifeStance also reported a net cash provided by operations of $64.4 million in the second quarter, and a positive free cash flow of $56.6 million [1].
For the full year 2025, LifeStance has raised its expectations for revenue to $1.40 billion to $1.44 billion, Center Margin to $441 million to $465 million, and Adjusted EBITDA to $140 million to $150 million. The company expects total revenue of $345 million to $365 million for the third quarter of 2025, Center Margin of $105 million to $119 million, and Adjusted EBITDA of $33 million to $39 million [1].
LifeStance has been expanding its AI and clinician initiatives, which have contributed to the growth in its clinician base. The company's mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable, and personalized mental healthcare [1].
References:
[1] https://finance.yahoo.com/news/lifestance-reports-second-quarter-2025-100000172.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet